US Patent

US10849857 — Pharmaceutical compositions comprising active drugs, contraceptive kits comprising active drugs, and methods of administering the same

Method of Use · Assigned to Laboratorios Leon Farma SA · Expires 2031-06-28 · 5y remaining

Vulnerability score 76/100 Vulnerable — likely target for IPR or design-around

What this patent protects

This patent protects methods of administering pharmaceutical compositions containing active contraceptive drugs, such as progestogen-only contraceptives like Drospirenone.

USPTO Abstract

The present invention relates to pharmaceutical compositions and kits comprising pharmaceutical compositions, and methods for administering pharmaceutical compositions comprising active contraceptive drugs in a patient. Specifically, the pharmaceutical compositions may comprise progestogen-only contraceptives (“POC”), such as Drospirenone.

Drugs covered by this patent

FDA Patent Use Codes

When a patent is method-of-use, FDA lists it once per applicable indication ("U-code"). Each U-code carves out a specific therapeutic use that generic filers must either license or design around.

CodeDescriptionDrug
U-2553 — Slynd
U-2553 — Slynd

Patent Metadata

Patent number
US10849857
Jurisdiction
US
Classification
Method of Use
Expires
2031-06-28
Drug substance claim
No
Drug product claim
Yes
Assignee
Laboratorios Leon Farma SA
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.